Potential role of myeloid cell/eosinophil-derived IL-17 in LPS-induced endotoxin shock

Biochemical and Biophysical Research Communications

Volumn 453, Issue 1, 2014, Pages 1-6

  Shimura, Eri ^a   Shibui, Akiko ^b   Narushima, Seiko ^b   Nambu, Aya ^b   Yamaguchi, Sachiko ^b   Akitsu, Aoi ^c   Leonard, Warren J ^d   Iwakura, Yoichiro ^c   Matsumoto, Kenji ^e   Suto, Hajime ^a   Okumura, Ko ^a   Sudo, Katsuko ^f   Nakae, Susumu ^b,g  

^a JUNTENDO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^f TOKYO MEDICAL UNIVERSITY   (Japan)

^g JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

IL 17A; IL 17F; IL 25; Sepsis

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR ALPHA; INTERLEUKIN 25; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; D17WSU104E PROTEIN, MOUSE; IL17A PROTEIN, MOUSE; IL17F PROTEIN, MOUSE; IL17R PROTEIN, MOUSE; IL21R PROTEIN, MOUSE; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; EOSINOPHIL; FEMALE; MACROPHAGE; MALE; MOUSE; NONHUMAN; SEPTIC SHOCK; T LYMPHOCYTE; TH17 CELL; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DEFICIENCY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; SHOCK, SEPTIC;

ANIMALS; EOSINOPHILS; FEMALE; INTERLEUKIN-17; INTERLEUKIN-21 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; INTERLEUKINS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; RECEPTORS, INTERLEUKIN-17; SHOCK, SEPTIC; TH17 CELLS;

EID: 84908345630     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.09.004     Document Type: Article

References (34)

1. Y. Iwakura, H. Ishigame, S. Saijo, and S. Nakae Functional specialization of interleukin-17 family members Immunity 34 2011 149 162
2. P. Miossec, and J.K. Kolls Targeting IL-17 and TH17 cells in chronic inflammation Nat. Rev. Drug Discov. 11 2012 763 776
3. E.A. Rickel, L.A. Siegel, B.R. Yoon, J.B. Rottman, and D.G. Kugler Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities J. Immunol. 181 2008 4299 4310
4. S.L. Gaffen Structure and signalling in the IL-17 receptor family Nat. Rev. Immunol. 9 2009 556 567
5. X.O. Yang, S.H. Chang, H. Park, R. Nurieva, and B. Shah Regulation of inflammatory responses by IL-17F J. Exp. Med. 205 2008 1063 1075
6. H. Li, J. Chen, A. Huang, J. Stinson, and S. Heldens Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family Proc. Natl. Acad. Sci. U.S.A. 97 2000 773 778
7. Y. Shi, S.J. Ullrich, J. Zhang, K. Connolly, and K.J. Grzegorzewski A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity J. Biol. Chem. 275 2000 19167 19176
8. Y. Iwakura, S. Nakae, S. Saijo, and H. Ishigame The roles of IL-17A in inflammatory immune responses and host defense against pathogens Immunol. Rev. 226 2008 57 79
9. M.R. Kim, R. Manoukian, R. Yeh, S.M. Silbiger, and D.M. Danilenko Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production Blood 100 2002 2330 2340
10. A.E. Price, H.E. Liang, B.M. Sullivan, R.L. Reinhardt, and C.J. Eisley Systemically dispersed innate IL-13-expressing cells in type 2 immunity Proc. Natl. Acad. Sci. U.S.A. 107 2010 11489 11494
11. S.A. Saenz, M.C. Siracusa, J.G. Perrigoue, S.P. Spencer, and J.F. Urban Jr. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses Nature 464 2010 1362 1366
12. P.G. Fallon, S.J. Ballantyne, N.E. Mangan, J.L. Barlow, and A. Dasvarma Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion J. Exp. Med. 203 2006 1105 1116
13. A.M. Owyang, C. Zaph, E.H. Wilson, K.J. Guild, and T. McClanahan Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract J. Exp. Med. 203 2006 843 849
14. A. Zhao, J.F. Urban Jr., R. Sun, J. Stiltz, and M. Morimoto Critical role of IL-25 in nematode infection-induced alterations in intestinal function J. Immunol. 185 2010 6921 6929
15. K. Oboki, T. Ohno, H. Saito, and S. Nakae Th17 and allergy Allergol. Int. 57 2008 121 134
16. T. Korn, E. Bettelli, M. Oukka, and V.K. Kuchroo IL-17 and Th17 Cells Annu. Rev. Immunol. 27 2009 485 517
17. D.J. Cua, and C.M. Tato Innate IL-17-producing cells: the sentinels of the immune system Nat. Rev. Immunol. 10 2010 479 489
18. M.A. Flierl, D. Rittirsch, H. Gao, L.M. Hoesel, and B.A. Nadeau Adverse functions of IL-17A in experimental sepsis FASEB J. 22 2008 2198 2205
19. M. Bosmann, V.R. Patel, N.F. Russkamp, F. Pache, and F.S. Zetoune MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway FASEB J. 25 2011 4222 4232
20. M. Bosmann, F. Meta, R. Ruemmler, M.D. Haggadone, and J.V. Sarma Regulation of IL-17 family members by adrenal hormones during experimental sepsis in mice Am. J. Pathol. 182 2013 1124 1130
21. M. Ogiku, H. Kono, M. Hara, M. Tsuchiya, and H. Fujii Interleukin-17A plays a pivotal role in polymicrobial sepsis according to studies using IL-17A knockout mice J. Surg. Res. 174 2012 142 149
22. A. Freitas, J.C. Alves-Filho, T. Victoni, T. Secher, and H.P. Lemos IL-17 receptor signaling is required to control polymicrobial sepsis J. Immunol. 182 2009 7846 7854
23. S. Nakae, Y. Komiyama, A. Nambu, K. Sudo, and M. Iwase Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses Immunity 17 2002 375 387
24. H. Ishigame, S. Kakuta, T. Nagai, M. Kadoki, and A. Nambu Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses Immunity 30 2009 108 119
25. A. Ishii, K. Oboki, A. Nambu, H. Morita, and T. Ohno Development of IL-17-mediated delayed-type hypersensitivity is not affected by down-regulation of IL-25 expression Allergol. Int. 59 2010 399 408
26. K. Ozaki, R. Spolski, C.G. Feng, C.F. Qi, and J. Cheng A critical role for IL-21 in regulating immunoglobulin production Science 298 2002 1630 1634
27. M. Pasparakis, L. Alexopoulou, V. Episkopou, and G. Kollias Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response J. Exp. Med. 184 1996 1397 1411
28. C. Dong TH17 cells in development: an updated view of their molecular identity and genetic programming Nat. Rev. Immunol. 8 2008 337 348
29. S.A. Dalrymple, R. Slattery, D.M. Aud, M. Krishna, and L.A. Lucian Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection Infect. Immun. 64 1996 3231 3235
30. D.G. Remick, D.E. Newcomb, G.L. Bolgos, and D.R. Call Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture Shock 13 2000 110 116
31. + regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis J. Immunol. 174 2005 7141 7146
32. P.J. Rauch, A. Chudnovskiy, C.S. Robbins, G.F. Weber, and M. Etzrodt Innate response activator B cells protect against microbial sepsis Science 335 2012 597 601
33. M. Bosmann, N.F. Russkamp, V.R. Patel, F.S. Zetoune, and J.V. Sarma The outcome of polymicrobial sepsis is independent of T and B cells Shock 36 2011 396 401
34. + regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis J. Immunol. 177 2006 7943 7949